Please Select... Contents Commercial Highlights Competitive Edge Unique Products Channel Strategy LiDCO and KOL Chairman’s Statement Chief Executive Officer’s Statement Financial Review Board of Directors Clinical Advisory Board Corporate Governance Corporate Social Responsibility Statement Directors' Remuneration Report Directors' Report Report of the Independent Auditors Consolidated Income Statement Consolidated Balance Sheet Consolidated Cash Flow Statement Consolidated Statement of changes Notes Report of the Independent Auditors Company Balance Sheet Notes Company Information Contact Details Search: | Full PDF report | Print this page |

Annual Report & Accounts 2008/9 - Commercial Highlights

Commercial Highlights Highest single year increase in installed monitor base. LiDCOplus & LiDCOrapid monitors installed base up 28% to 1,510. Successful launch of the LiDCOrapid; 279 monitors sold or placed in first ten months. New distributors added for 18 territories. LiDCO products are now available in 47 countries worldwide. Continued progress to profitability and significant increase in level of recurring revenue. 326 monitors sold or placed in the period up 116% (2007/08: 151). Monitor revenue steady at £1.96m (2007/08: £1.93m). Disposables income growth in all territories up 26% from £1.99m to £2.50m. Selected as technology for two US multi-centre patient outcome studies. LiDCO Group Plc Welcome LiDCO researches, develops, manufactures and markets innovative medical devices. Our products primarily serve critical-care and cardiovascular risk hospital patients who require real-time cardiovascular monitoring. 01 LiDCO Annual Report 2008/09